Where Is the Medicine?

Headlines regularly announce promising scientific discoveries. Yet the path from a discovery to a medicine that can be given to patients is long, uncertain, and shaped by decisions that rarely appear in the headline.

Where Is the Medicine? opens that hidden journey to the general reader through eight Israeli analogies. Mossad, Unit 8200, Iron Dome, Taftefet, Krav Maga, Beresheet, Pegasus, and Sorek illuminate how drug-development teams define the mission, interpret evidence, decide where to invest, adapt when clinical reality differs from prediction, learn from failure, anticipate resistance, and build a medicine that can be produced reliably and used by patients.

Along the way, the book explains why a promising scientific discovery is not yet a treatment; why a drug can affect its intended target without becoming an effective medicine; why dose, safety, biomarkers, patient selection, manufacturing, and clinical-trial design all matter; and why even a negative result can provide valuable information for the next decision.

Written for readers without scientific or medical training, Where Is the Medicine? provides a clear framework for understanding what really has to happen between a breakthrough headline and a medicine that reaches patients.